Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2020 5
2021 7
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological treatments of COVID-19.
Sahebnasagh A, Avan R, Saghafi F, Mojtahedzadeh M, Sadremomtaz A, Arasteh O, Tanzifi A, Faramarzi F, Negarandeh R, Safdari M, Khataminia M, Rezai Ghaleno H, Habtemariam S, Khoshi A. Sahebnasagh A, et al. Among authors: safdari m. Pharmacol Rep. 2020 Dec;72(6):1446-1478. doi: 10.1007/s43440-020-00152-9. Epub 2020 Aug 20. Pharmacol Rep. 2020. PMID: 32816200 Free PMC article. Review.
Aromatic hydrocarbon receptors in mitochondrial biogenesis and function.
Sahebnasagh A, Hashemi J, Khoshi A, Saghafi F, Avan R, Faramarzi F, Azimi S, Habtemariam S, Sureda A, Khayatkashani M, Safdari M, Rezai Ghaleno H, Soltani H, Khayat Kashani HR. Sahebnasagh A, et al. Among authors: safdari m. Mitochondrion. 2021 Nov;61:85-101. doi: 10.1016/j.mito.2021.09.012. Epub 2021 Sep 30. Mitochondrion. 2021. PMID: 34600156 Review.
The prophylaxis and treatment potential of supplements for COVID-19.
Sahebnasagh A, Saghafi F, Avan R, Khoshi A, Khataminia M, Safdari M, Habtemariam S, Ghaleno HR, Nabavi SM. Sahebnasagh A, et al. Among authors: safdari m. Eur J Pharmacol. 2020 Nov 15;887:173530. doi: 10.1016/j.ejphar.2020.173530. Epub 2020 Sep 1. Eur J Pharmacol. 2020. PMID: 32882216 Free PMC article. Review.
Prospective therapeutic potential of Tanshinone IIA: An updated overview.
Ansari MA, Khan FB, Safdari HA, Almatroudi A, Alzohairy MA, Safdari M, Amirizadeh M, Rehman S, Equbal MJ, Hoque M. Ansari MA, et al. Among authors: safdari m. Pharmacol Res. 2021 Feb;164:105364. doi: 10.1016/j.phrs.2020.105364. Epub 2020 Dec 4. Pharmacol Res. 2021. PMID: 33285229 Review.
Nitric Oxide and Immune Responses in Cancer: Searching for New Therapeutic Strategies.
Sahebnasagh A, Saghafi F, Negintaji S, Hu T, Shabani-Borujeni M, Safdari M, Ghaleno HR, Miao L, Qi Y, Wang M, Liao P, Sureda A, Simal-Gándara J, Nabavi SM, Xiao J. Sahebnasagh A, et al. Among authors: safdari m. Curr Med Chem. 2022;29(9):1561-1595. doi: 10.2174/0929867328666210707194543. Curr Med Chem. 2022. PMID: 34238142 Review.
Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
Sahebnasagh A, Saghafi F, Safdari M, Khataminia M, Sadremomtaz A, Talaei Z, Rezai Ghaleno H, Bagheri M, Habtemariam S, Avan R. Sahebnasagh A, et al. Among authors: safdari m. J Clin Pharm Ther. 2020 Dec;45(6):1515-1519. doi: 10.1111/jcpt.13251. Epub 2020 Aug 28. J Clin Pharm Ther. 2020. PMID: 32860252 Review.
A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.
Sahebnasagh A, Mojtahedzadeh M, Najmeddin F, Najafi A, Safdari M, Rezai Ghaleno H, Habtemariam S, Berindan-Neagoe I, Nabavi SM. Sahebnasagh A, et al. Among authors: safdari m. Arch Med Res. 2020 Oct;51(7):631-635. doi: 10.1016/j.arcmed.2020.08.002. Epub 2020 Aug 11. Arch Med Res. 2020. PMID: 32863034 Free PMC article. Review.
16 results